New research on GLP-1 medications identifies potential bone loss risks among 147,000 adults with type 2 diabetes and obesity.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
What doctors want you to know about GLP-1s and bone loss
147,000 people Adults examined
3 conditions Conditions associated with GLP-1 use
Observational Study design type
Not Yet Peer Reviewed Peer review status